Ray-CRO

Ray-CRO, established in 2010, is a regional full-service Contract Research Organization (CRO) specializing in clinical trials, medical affairs, pharmacovigilance, and regulatory services. The company is dedicated to advancing research in chronic and complex diseases, providing cost-effective solutions to pharmaceutical and biotech clients. With a strategic focus on patient-centered outcomes and real-world evidence insights, Ray-CRO supports multinational clinical trials and navigates complex regulatory challenges. Its operations are rooted in the business services sector, specifically within the life sciences domain, serving clients across Africa and the Middle East.

Operating with a dedicated team of experts and leveraging cutting-edge technology, Ray-CRO enhances drug safety practices and accelerates research timelines. The organization employs between 500 - 1,000 professionals, contributing to its capacity to manage diverse research projects. For detailed information on the personnel driving these critical functions and their expertise, explore Meet Ray-CRO's team. The company's operational scale is supported by its presence in two distinct locations, facilitating its regional service delivery and client support.

Ray-CRO's commitment to quality and efficiency positions it as a trusted partner in the clinical research landscape. By offering specialized expertise in areas such as chronic disease research and regulatory compliance, the company addresses key industry needs. Its revenue stands at $13.7M, reflecting its market engagement and service provision. The company's business-to-business (B2B) model emphasizes collaboration and tailored support for its pharmaceutical and biotech clientele, aiming to foster innovation and improve patient care through rigorous scientific investigation.